Cutaneous adverse events due to checkpoint inhibitors – a retrospective analysis at a tertiary referral hospital in Switzerland 2019-2022
2024

Skin Side Effects from Cancer Immunotherapy

Sample size: 431 publication 10 minutes Evidence: moderate

Author Information

Author(s): Clara Furrer-Matcau, Chloé Sieber, Dirk Lehnick, Christoph Urs Brand, Balthasar Hug

Primary Institution: Cantonal Hospital Lucerne, Lucerne, Switzerland

Hypothesis

What is the incidence and impact of skin side effects caused by checkpoint inhibitor therapy in cancer patients?

Conclusion

About one third of patients experienced mild skin side effects from immunotherapy, which were mostly manageable with topical treatments.

Supporting Evidence

  • 30.4% of patients experienced at least one skin side effect.
  • Pruritus was the most common side effect, affecting 25.3% of patients.
  • 67.2% of patients with skin side effects required no treatment or only topical treatment.
  • 15 patients had to stop immunotherapy due to severe skin side effects.

Takeaway

Some cancer treatments can cause skin problems, but most of them are not serious and can be treated easily.

Methodology

This is a descriptive, monocentric retrospective study using electronic health records from a hospital in Switzerland.

Potential Biases

Reporting bias for mild adverse events cannot be excluded.

Limitations

The study is limited by its retrospective design and the inability to classify data according to standardized criteria.

Participant Demographics

{"median_age":67,"age_range":"21-93","gender_distribution":{"male":64.7,"female":35.3}}

Digital Object Identifier (DOI)

10.3389/fonc.2024.1485594

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication